Engage Biologics Inc. (“Engage”), a preclinical biotechnology company pioneering non-viral DNA delivery, today announced that it has been acquired by Eli Lilly and Company (“Lilly”). Engage is ...
Ansa Biotechnologies’ CEO Daniel Lin-Arlow’s passion is helping scientists do their job faster and deliver their innovation to the world. His latest solution? Enzymatic DNA synthesis. DNA writing is ...
Matthew Hayes (Left) is the Chief Technology Officer and founder at Evonetix, a groundbreaking gene synthesis technology company created in 2015, where he deploys his expertise in multi-disciplinary ...
Ellis Bio today announced that an independent evaluation by Roche, published in a new Tech Spotlight, found that the ...
DNA, the language of biology, is driving all synthetic biology applications, from animal-free meat to life-saving therapeutics. It should come as no surprise that DNA synthesis is a hot and ...
SAN DIEGO--(BUSINESS WIRE)--Boundless Bio, a clinical stage next-generation precision oncology company developing innovative therapeutics directed against extrachromosomal DNA (ecDNA) in oncogene ...
Scientists at Children's Medical Center Research Institute at UT Southwestern (CRI) have discovered that large pieces of DNA ...
The shape and morphology of a cell play a key role in the biological function. This corresponds to the principle of "form follows function," which is common in modern fields of design and architecture ...
STONY BROOK, N.Y.--(BUSINESS WIRE)--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in cell-free, enzymatic DNA production, today announced the publication of a manuscript ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results